Filippo Fagni

Department of Medicine 3 – Rheumatology and Immunology

At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement (2022) Bond M, Fagni F, Moretti M, Bello F, Egan A, Vaglio A, Emmi G, Dejaco C Journal article, Review article Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy? (2022) Fagni F, Simon D Journal article, Editorial Fibroblast Activation in Psoriasis Patients Assessed by Ga-68-FAPI-04 PET-CT Is Associated with Progression to Psoriatic Arthritis (2022) Fagni F, Simon D, Kleyer A, Tascilar K, Taubmann J, Bayat S, Minopoulou I, et al. Conference contribution Cinematic rendering in rheumatic diseases-Photorealistic depiction of pathologies improves disease understanding for patients (2022) Pachowsky M, Morf H, Simon D, Schönau V, Valor-Mendez L, Knitza J, Fagni F, et al. Journal article Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis-A case report and literature review (2022) Yalcin Mutlu M, Taubmann J, Wacker J, Tascilar K, Fagni F, Gerner M, Klett D, et al. Journal article Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography (2022) Tascilar K, Fagni F, Kleyer A, Bayat S, Heidemann R, Steiger F, Krönke G, et al. Journal article IDENTIFICATION OF CIRCULATING MICRORNA SIGNATURES IN PATIENTS WITH PSORIASIS WITH SUBCLINICAL JOINT DISEASE AND PATIENTS WITH PSORIATIC ARTHRITIS (2022) Haschka J, Simon D, Bayat S, Messner Z, Kampylafka E, Fagni F, Skalicky S, et al. Conference contribution, Abstract of a poster LONG-TERM HUMORAL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE (2022) Tascilar K, Simon D, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, et al. Conference contribution NON-INVASIVE IN VIVO METABOLIC PROFILING OF INFLAMMATION IN JOINTS AND ENTHESES BY OPTOACOUSTIC IMAGING (2022) Tascilar K, Fagni F, Kleyer A, Bayat S, Heidemann R, Steiger F, Krönke G, et al. Conference contribution PRE-EXPOSURE PROPHYLAXIS FOR SARS-COV-2 INFECTION WITH SUBCUTANEOUS CASIRIVIMAB/IMDEVIMAB IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES. (2022) Fagni F, Schmidt K, Bohr D, Valor L, Hartmann F, Tascilar K, Manger K, et al. Conference contribution